Esophageal Adenocarcinoma Clinical Trials in Dallas, Texas

8 recruitingDallas, Texas

Showing 18 of 8 trials

Recruiting
Phase 1

Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors

Biliary Tract CancerEsophageal AdenocarcinomaGastric Adenocarcinoma+2 more
SystImmune Inc.160 enrolled17 locationsNCT07021066
Recruiting
Phase 3

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+12 more
Alliance for Clinical Trials in Oncology382 enrolled791 locationsNCT05677490
Recruiting
Phase 1

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

Gastric CancerEsophageal AdenocarcinomaMetastatic Cancer+5 more
I-Mab Biopharma US Limited330 enrolled21 locationsNCT04900818
Recruiting
Phase 1

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Ovarian CancerCervical CancerEndometrial Cancer+6 more
Normunity AccelCo, Inc.150 enrolled9 locationsNCT07182149
Recruiting
Phase 1

A Study of KK2269 in Adult Participants With Solid Tumors

Advanced Solid TumorMetastatic Solid TumorEsophageal Adenocarcinoma+2 more
Kyowa Kirin Co., Ltd.101 enrolled11 locationsNCT06266299
Recruiting
Not Applicable

Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma

Esophageal AdenocarcinomaBarrett Esophagus
Mayo Clinic1,550 enrolled9 locationsNCT03961945
Recruiting
Not Applicable

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

Esophageal AdenocarcinomaBarrett EsophagusBarretts Esophagus With Dysplasia
University of Colorado, Denver680 enrolled23 locationsNCT05753748
Recruiting
Phase 2

A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

Esophageal Squamous Cell CarcinomaEsophageal AdenocarcinomaGastroesophageal Junction Carcinoma
VA Office of Research and Development78 enrolled7 locationsNCT05563766